Literatur
-
1
Boulhadour H, Cherque D, Charlotte F, Rahmouni A, Dhumeaux D, Zafrani E, Meignan M.
The hot spot hepatobiliary scan in focul nodular hyperplasia.
J Nucl Med.
1993;
34
2105-2110
-
2
Neumann M C, Schober O.
Nuklearmedizinische Diagnostik der Leber.
Radiologe.
2000;
40
916-924
-
3
Sciuk J, Schober O.
Nuklearmedizinische Diagnostik von Raumforderungen in der Leber.
Internist.
1997;
38
917-923
-
4
Kotzerke J, Schwarzrock R, Krischek O, Wiese H, Hundeshagen H.
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma, adenoma, and focal nodular hyperplasia.
[Letter to the Editor]. J Nucl Med.
1989;
30
1278-1279
-
5
Gratz K F, Creutzig H, Brölsch C, Neuhaus P, Majewski A, Pichlmayr R, Hundeshagen H.
Choleszintigraphie zum Nachweis der focal-nodulären Hyperplasie (FNH) der Leber?.
Chirurg.
1984;
55
448-451
-
6
Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz K F, Prokop M, Maschek H, Tusch G, Pichlmayr R.
Benign liver tumors: Differential diagnosis and indications for surgery.
World J Surg.
1997;
21
983-991
-
7
Bucerius J, Kinkel B, Mallek von D, Lauschke H, Biersack H J, Reinhardt M J.
Stellenwert der Leberfunktionsszintigraphie (99mTC-HIDA) im Rahmen der Differenzialdiagnose unklarer hepatischer Raumforderungen.
Endo heute.
2004;
17
112-117
-
8 Schicha H, Wellner U. Dosimetrie. In: Schicha H, Schober O (Hrsg). Nuklearmedizin. 5. Auflage. Schattauer, Stuttgart, New York 2003; 88-109
-
9
Abdel-Nabi H, Abou-Zied M M, Doerr R J.
Preoperative evaluation of patients with suspected liver metastases with positron emission tomography with F-18FDG [abstract].
J Nucl Med.
1999;
40
241 P-241P
-
10
Abdel-Nabi H, Doerr R J, Lamonica D M. et al .
Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Radiology.
1998;
206
755-760
-
11
Bipat S, van Leeuwen M S, Comans E FI. et al .
Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis.
Radiology.
2005;
237
123-131
-
12
Wiering B, Krabbe P FM, Jager G J, Oyen W JG, Ruers T JM.
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases - A systematic review and metaanalysis.
Cancer.
2005;
104
2658-2670
-
13
Antoch G, Saoudi N, Kuehl H. et al .
Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET / CT) for tumor staging in solid tumors: comparison with CT and PET.
J Clin Oncol.
2004;
22
4357-4368
-
14
Trojan J, Schroeder O, Raedle J. et al .
Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Am J Gastroenterol.
1999;
94
3314-3319
-
15
Krause T, Jüngling F.
Nuklearmedizinische Diagnostik von Raumforderungen der Leber.
Der Nuklearmediziner.
2003;
26
92-95
-
16
Khan M A, Combs C S, Brunt E M,. et al .
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.
J Hepatol.
2000;
32
792-797
-
17
Teefey S A, Hildeboldt C C, Dehdashti F. et al .
Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MRT imaging, US, and PET.
Radiology.
2003;
226
533-542
-
18
Ho C L, Yu S CH, Yeung D WC.
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
J Nucl Med.
2003;
44
213-221
-
19
Talbot J N, Gutman F, Fartoux L. et al .
PET / CT in patients with hepatocellular carcinoma using [18F] fluorocholine: preliminary comparison with [18F]FDG PET / CT.
Eur J Nucl Med Mol Imaging.
2006;
, Epub ahead of print
Dr. med. J. Bucerius
Klinik und Poliklinik für Nuklearmedizin · Universität Bonn
Sigmund-Freud-Str. 25
53105 Bonn
Telefon: 02 28/28 71 51 81
Fax: 02 28/28 71 90 96
eMail: jan.bucerius@ukb.uni-bonn.de
